CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities attributable to continuing operations:
Net earnings	$ 276,508	$ 445,278
Add back: earnings from discontinued operations, net of tax	0	(509)
Net earnings from continuing operations	276,508	444,769
Adjustments to reconcile net earnings from continuing operations to net cash provided by operating activities attributable to continuing operations:
Stock-based compensation expense	150,324	112,081
Depreciation	32,664	30,622
Impairment and amortization of intangibles	251,838	15,521
Deferred income taxes	6,517	(21,749)
Other adjustments, net	1,362	49,761
Changes in assets and liabilities
Accounts receivable	6,985	(26,618)
Other assets	53,757	17,729
Accounts payable and other liabilities	(467,343)	(4,059)
Income taxes payable and receivable	(11,721)	18,443
Deferred revenue	(440)	30,425
Net cash provided by operating activities attributable to continuing operations	300,451	666,925
Cash flows from investing activities attributable to continuing operations:
Cash used in business combinations, net of cash acquired	(25,681)	(863,258)
Capital expenditures	(38,373)	(52,811)
Other, net	2,615	26
Net cash used in investing activities attributable to continuing operations	(61,439)	(916,043)
Cash flows from financing activities attributable to continuing operations:
Payments to settle exchangeable notes	(117,755)	0
Proceeds from the settlement of exchangeable note hedges	61,459	0
Payments to settle warrants related to exchangeable notes	(7,482)	0
Debt issuance costs	0	(851)
Proceeds from issuance of common stock pursuant to stock-based awards	16,788	45,587
Withholding taxes paid on behalf of employees on net settled stock-based awards	(106,688)	(15,726)
Purchase of treasury stock	(482,049)	0
Purchase of noncontrolling interests	(10,554)	(1,473)
Other, net	10	150
Net cash (used in) provided by financing activities attributable to continuing operations	(646,271)	27,687
Total cash used in continuing operations	(407,259)	(221,431)
Net cash used in operating activities attributable to discontinued operations	0	0
Net cash used in investing activities attributable to discontinued operations	0	0
Net cash used in financing activities attributable to discontinued operations	0	0
Total cash used in discontinued operations	0	0
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(17,501)	(6,429)
Net decrease in cash, cash equivalents, and restricted cash	(424,760)	(227,860)
Cash, cash equivalents, and restricted cash at beginning of period	815,512	739,302
Cash, cash equivalents, and restricted cash at end of period	$ 390,752	$ 511,442